Compagnie Lombard Odier SCmA’s Zimmer Biomet ZBH Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,900	Closed	-$171K	–	448
2025 Q4	$171K	Sell	1,900 -200	-10%	-$19K	﹤0.01%	259
2025 Q3	$207K	Hold	2,100	–	–	﹤0.01%	250
2025 Q2	$192K	Hold	2,100	–	–	﹤0.01%	243
2025 Q1	$238K	Hold	2,100	–	–	﹤0.01%	245
2024 Q4	$222K	Hold	2,100	–	–	﹤0.01%	236
2024 Q3	$227K	Hold	2,100	–	–	﹤0.01%	233
2024 Q2	$228K	Sell	2,100 -230	-10%	-$27.1K	﹤0.01%	236
2024 Q1	$308K	Hold	2,330	–	–	0.01%	222
2023 Q4	$284K	Buy	2,330 +1,900	+442%	+$212K	0.01%	251
2023 Q3	$48.3K	Hold	430	–	–	﹤0.01%	428
2023 Q2	$62.6K	Hold	430	–	–	﹤0.01%	396
2023 Q1	$55.6K	Sell	430 -3,000	-87%	-$377K	﹤0.01%	434
2022 Q4	$436K	Buy	3,430 +3,000	+698%	+$348K	0.01%	203
2022 Q3	$45K	Hold	430	–	–	﹤0.01%	470
2022 Q2	$45K	Hold	430	–	–	﹤0.01%	459
2022 Q1	$55K	Sell	430 -13	-3%	-$1.57K	﹤0.01%	436
2021 Q4	$54K	Hold	443	–	–	﹤0.01%	495
2021 Q3	$62K	Hold	443	–	–	﹤0.01%	483
2021 Q2	$69K	Hold	443	–	–	﹤0.01%	455
2021 Q1	$69K	Hold	443	–	–	﹤0.01%	478
2020 Q4	$67K	Buy	443 +206	+87%	+$29.1K	﹤0.01%	412
2020 Q3	$31K	Sell	237 -271	-53%	-$35.4K	﹤0.01%	430
2020 Q2	$59K	Hold	508	–	–	﹤0.01%	366
2020 Q1	$49K	Hold	508	–	–	﹤0.01%	350
2019 Q4	$75K	Buy	508 +165	+48%	+$22.8K	﹤0.01%	338
2019 Q3	$46K	Sell	343 -100	-23%	-$12.9K	﹤0.01%	366
2019 Q2	$51K	Buy	443 +206	+87%	+$24.1K	﹤0.01%	358
2019 Q1	$29K	Hold	237	–	–	﹤0.01%	443
2018 Q4	$24K	Hold	237	–	–	﹤0.01%	440
2018 Q3	$30K	Hold	237	–	–	﹤0.01%	467
2018 Q2	$26K	Buy	+237	New	+$25.8K	﹤0.01%	511
2017 Q1	–	Sell	-670	Closed	-$67K	–	847
2016 Q4	$67K	Hold	670	–	–	﹤0.01%	574
2016 Q3	$85K	Hold	670	–	–	﹤0.01%	600
2016 Q2	$78K	Hold	670	–	–	﹤0.01%	602
2016 Q1	$69K	Sell	670 -33	-5%	-$3.19K	﹤0.01%	679
2015 Q4	$70K	Sell	703 -2,070	-75%	-$203K	﹤0.01%	648
2015 Q3	$253K	Buy	2,773 +1,691	+156%	+$170K	0.01%	375
2015 Q2	$115K	Sell	1,082 -309	-22%	-$34.2K	﹤0.01%	534
2015 Q1	$158K	Buy	1,391 +670	+93%	+$76.4K	0.01%	540
2014 Q4	$79K	Sell	721 -684	-49%	-$72.1K	﹤0.01%	580
2014 Q3	$137K	Hold	1,405	–	–	0.01%	585
2014 Q2	$142K	Sell	1,405 -515	-27%	-$50.2K	0.01%	600
2014 Q1	$176K	Hold	1,920	–	–	0.01%	548
2013 Q4	$174K	Buy	+1,920	New	+$166K	0.01%	556

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Compagnie Lombard Odier SCmA's ZBH Position: Q1 2026 in Review

Compagnie Lombard Odier SCmA sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 1,900 shares — an estimated $171K sold.

Compagnie Lombard Odier SCmA first reported a position in ZBH in Q4 2013 and held it in 44 quarters. The position peaked at $436K in Q4 2022. 913 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Compagnie Lombard Odier SCmA reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 1,900 Zimmer Biomet shares in Q1 2026, an estimated $171K.
Compagnie Lombard Odier SCmA first reported a position in Zimmer Biomet in Q4 2013 and held it in 44 quarters.
Compagnie Lombard Odier SCmA's Zimmer Biomet position peaked at $436K in Q4 2022.
913 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2026, filed 15 Apr 2026.